Additionally, Ye et al. identified miR-429 as a regulator of the VEGFA pathway in ovarian cancer tissue, highlighting its potential as a future diagnostic and therapeutic biomarker [48]. The gene discussed is VEGFA; the disease is ovarian cancer.